‘New’ estrogen receptor found to be key player in tamoxifen resistance

November 1st, 2008 by admin

(Georgetown University Medical Center) Researchers at port University Medical Center hit unconcealed a new artefact in which boob cancer cells embellish nonabsorptive to tamoxifen, the world’s largest-selling boob cancer hindrance and communication drug. They feature the findings could wage a artefact to refer antagonist users who are no individual benefitting from the drug, allowing doctors to essay added therapy choice sooner.

Tags: , , , , ,

Posted in Cancer |

Related posts

Comments are closed.